Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2238 of 5804
-
Robot scalpel takes on Alzheimer's: tiny neck surgery aims to clear brain waste
Disease control Recruiting nowThe objective of this investigational device exemption (IDE) study is to evaluate the safety and feasibility of using the Symani System and microsurgical techniques in the deep cervical lymph node (dCLN) region in the setting of mild to moderate Alzheimer's disease and lymphatic …
Phase: NA • Sponsor: MMI (Medical Microinstruments, Inc.) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New custom pessary aims to solve fit problems for pelvic organ prolapse
Symptom relief Recruiting nowPelvic organ prolapse (POP) is a common health issue. It will impact about half of Canadian women over their lifetime. With POP, organs like the bladder, uterus, and bowel may push into the vagina. Women may experience urine leakage, physical discomfort, and embarrassment. Aside …
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Heart-Saving hope: melatonin and vitamin d tested in breast cancer patients
Symptom relief Not yet recruitingThis study aims to assess the cardioprotective effect of melatonin and vitamin D in breast cancer patients who receive doxorubicin.
Phase: NA • Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
New nanocrystal drug aims to fight cancer wasting during chemoradiation
Symptom relief Recruiting nowCervical cancer, ranking as the fourth most prevalent malignancy in women globally, presents significant challenges in nutritional management. Approximately 31% of patients develop cancer-related malnutrition/cachexia, with 10-20% of deaths directly attributable to nutritional de…
Phase: PHASE1 • Sponsor: Second Xiangya Hospital of Central South University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can a newer drug protect heart health after kidney transplant?
Disease control Recruiting nowKidney transplantation is the standard treatment for patients with end-stage renal failure. However, anticalcineurin inhibitors, the most widely used immunosuppressants, are involved in the occurrence of cardiovascular events, a major cause of premature death in these patients. …
Phase: PHASE4 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for lung cancer patients: drug combo aims to stop chemo-radiation sickness
Symptom relief Not yet recruitingThis study aims to evaluate the efficacy and safety of a combination regimen based on Rolapitant Palonosetron injection for preventing nausea and vomiting induced by concurrent chemoradiotherapy in lung cancer patients. It will also analyze the differences in preventive efficacy …
Phase: NA • Sponsor: Henan Cancer Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New strategy aims to tame treatment side effects in lung cancer patients
Symptom relief Not yet recruitingThis study aims to explore the clinical outcomes of Comprehensive Enhanced Preventive Management (CEPM) combined with an amivantamab-containing treatment regimen in Chinese patients with EGFR-mutated advanced NSCLC.
Phase: PHASE4 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Can your own blood cure your hives? new trial investigates
Disease control Not yet recruitingTo evaluate the efficacy of Autologous Whole Blood Therapy versus conventional treatment using fourfold dose of antihistamines in Autologus serum skin test (ASST) positive and negative Chronic Idiopathic Urticaria (CIU) patients and suggest its possible mechanism of action.
Phase: PHASE3 • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for metastatic prostate cancer? early trial of GLR2037 begins
Disease control Not yet recruitingA Phase I Clinical Study of GLR2037 in Patients with Advanced Prostate Cancer
Phase: PHASE1 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Heart rehab hope for rare amyloidosis patients
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if a structured cardiac rehabilitation program can help people with cardiac amyloidosis improve their ability to exercise and their quality of life. The main questions it aims to answer are: Does cardiac rehabilitation raise peak oxyge…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New lupus drug candidate enters human safety testing
Disease control Not yet recruitinghis study is a randomized, double-blinded, and placebo-controlled phase Ia clinical study in subjects with SLE. The study is designed to assess the safety and tolerability of IASO-782 for the treatment of SLE.
Phase: PHASE1 • Sponsor: Shanghai IASO Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New study tests suction tools to make kidney stone surgery safer
Disease control Not yet recruitingKidney stones are a common health problem and may recur frequently, which can affect quality of life and kidney function. Retrograde intrarenal surgery (RIRS) is a minimally invasive treatment used for renal stones, but treatment of medium-sized stones may be associated with long…
Phase: NA • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New leg therapy aims to get stroke patients back on their feet
Symptom relief Not yet recruitingThis study aims to investigate the effects of a proprioceptive neuromuscular facilitation (PNF)-based lower extremity rehabilitation program on balance, gait performance, functional independence, and quality of life in individuals with stroke. Stroke is a leading cause of long-t…
Phase: NA • Sponsor: Istanbul Medipol University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New hope for Tick-Bite survivors: mast cell drugs aim to ease lingering symptoms
Symptom relief Not yet recruitingThis is a Phase II double-blinded study to assess the safety, tolerability, and feasibility of the mast cell stabilizing medications ketotifen and cromolyn compared to participants receiving standard of care treatment with fexofenadine alone in participants who have persistent sy…
Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
AI tool aims to spot head and neck cancer risk early
Knowledge-focused Not yet recruitingThis study aims to develop and validate a clinical prediction model for the risk of head and neck cancerous lesions using deep learning combined with AI algorithms, based on multi-center clinical data.
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Scientists hunt for clues to chemo allergies in kids with leukemia
Knowledge-focused Not yet recruitingAcute lymphoblastic leukemia is a type of blood cancer that primarily affects children. Fortunately, current treatments are highly effective. One of the key drugs used is asparaginase, which works by depriving leukemic cells of a substance that is essential for their survival. H…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Robot suit aims to steady aging and Parkinson's steps
Symptom relief Recruiting nowThis study will evaluate whether a wearable robotic exoskeleton can improve mobility, balance, and walking in healthy older adults and in individuals living with Parkinson's disease, populations at high risk of falls and mobility limitations. Participants will attend two laborato…
Phase: NA • Sponsor: Centre intégré de santé et de services sociaux de l'Outaouais • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Experimental RNA vaccine takes on advanced lung cancer
⭐️ VACCINE ⭐️ Recruiting nowThis is an open-label, single-arm, non-randomized, single-center, prospective phase 1 clinical trial. The study will evaluate the safety, tolerability, and preliminary antitumor activity of IMP3-saRNA (YMN-136) vaccine in patients with advanced non-small cell lung cancer. IMP3-s…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:31 UTC
-
Heart rate clues could unmask hidden sleep apnea in hypertensive patients
Knowledge-focused Recruiting nowThis study aims to investigate the relationship between hypertension and obstructive sleep apnea (OSA) using heart rate variability (HRV) as a non-invasive biomarker of autonomic nervous system function. Hypertensive patients at high risk for OSA will undergo 24-hour Holter elec…
Sponsor: Kaohsiung Armed Forces General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Yoga in schools may ease exam jitters for teens
Symptom relief CompletedThis cluster randomized controlled trial evaluates the effects of a yoga therapy program grounded in the Neuman Systems Model on test anxiety, quality of life, and mindfulness among eighth-grade students aged 13-14 years in Denizli, Türkiye. The study was conducted with students …
Phase: NA • Sponsor: Pamukkale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC